NeuroGlove
St. Louis Park, US · Founded 2022 · Delaware LLC
Founders & leadership
TW
Thomas W. HaroldNamed on SEC filing
LN
Leslie NussbaumNamed on SEC filing
EN
Eric NussbaumNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$1M disclosed across 1 round · 2022
▶$1MraisedDec 2022 · 1 investors · Other Health CareRule 506(b)
▶$1MraisedDec 2022 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Thomas W. HaroldExecutive Officer, Director
- Leslie NussbaumDirector
- Eric NussbaumExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $1M
- Minimum investment
- $1M
- First sale
- Dec 2022
- Incorporated
- Limited Liability Company, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has NeuroGlove raised?
- NeuroGlove has disclosed $1M raised across 1 round.
- Where is NeuroGlove headquartered?
- NeuroGlove is headquartered in St. Louis Park, US.